Prostate-specific antigen as a screening test: The Netherlands experience

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 307-314

  Bangma, C H ^a   Rietbergen, J B W ^a   Schroder, F H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030971794     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70377-3     Document Type: Article

References (15)

1. C.H. Bangma R. Kranse B.G. Blijenberg The value of screening tests in the detection of prostate cancer: 1. Results of a retrospective evaluation of 1726 men. 2. A simulation of the role of the F/T ratio, age specific reference ranges, and PSA density Urology 46 1995 773 784
2. M.C. Benson I.S. Whang A. Pantuck The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen J Urol 147 1992 817 821
3. F.M. Bentvelsen F.H. Schro¨der Modalities available for screening for prostate cancer Eur J Cancer 29A 1993 804 811
4. M.K. Brawer M.P. Chetner J. Beatie Screening for prostatic carcinoma with prostate specific antigen J Urol 147 1992 841 845
5. W.J. Catalona J.P. Richie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in early detection of prostate cancer: Results of multicenter clinical trial of 6630 men J Urol 151 1994 1283 1290
6. J.L. Epstein P.C. Walsh M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
7. F. Labrie A. Dupont R. Suburu Serum prostate specific antigen as pre-screening test for prostate cancer J Urol 147 1992 846 852
8. C. Mettlin F. Lee J. Drago The American Cancer Society National Prostate Cancer Detection Project, findings on the detection of early prostate cancer in 2425 men Cancer 67 1991 2949 2958
9. J.E. Oesterling S.J. Jacobsen W.H. Cooner Use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older J Urol 153 1995 1160 1163
10. M. Ohori P.T. Scardino Early detection of prostate cancer: The nature of cancers detected with current diagnostic tests Semin Oncol 21 1994 522 526
11. J.B.W. Rietbergen W.J. Kirkels R. Kranse Clinical relevance of T1c prostate cancer in population based screening study (ERSPC) [abstract] J Urol 155 1996 257
12. R. Scaletscky M.O. Koch C.W. Eckstein Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen J Urol 152 1994 129 131
13. F.H. Schroder P. Boyle Screening for prostate cancer: Necessity or nonsense Eur J Cancer 29A 1993 656 661
14. F.H. Schro¨der L.J. Denis W. Kirkels European Randomized Study of Screening for Prostate Cancer, progress report of Antwerp and Rotterdam pilot studies Cancer 76 1995 129 134
15. U. Stenman J. Leinonen H. Alfthan A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer Cancer Res 51 1991 222 226